| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.500 | None | 0.976 | 0 | 0 | 2002 | 2020 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.390 | None | 1.000 | 0 | 0 | 2015 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.700 | strong | 0.950 | 0 | 0 | 2010 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.983 | 0 | 0 | 1986 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.953 | 0 | 0 | 1996 | 2018 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.700 | strong | 0.961 | 0 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | strong | 0.950 | 0 | 0 | 1994 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.986 | 0 | 0 | 1996 | 2020 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 1993 | 2014 | ||||||||
|
damage specific DNA binding protein 2 | 0.576 | 0.654 | 7.4E-06 |
|
disease | 0.420 | None | 1.000 | 0 | 0 | 2006 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.917 | 0 | 0 | 2009 | 2018 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.500 | None | 0.938 | 0 | 0 | 2001 | 2019 | ||||||||
|
ERCC excision repair 3, TFIIH core complex helicase subunit | 0.504 | 0.846 | 3.4E-11 |
|
disease | 0.420 | None | 1.000 | 0 | 0 | 2013 | 2019 | ||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
disease | 0.450 | None | 1.000 | 0 | 0 | 2007 | 2016 | ||||||||
|
ERCC excision repair 5, endonuclease | 0.499 | 0.731 | 2.7E-13 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2006 | 2015 | ||||||||
|
G protein subunit alpha 11 | 0.563 | 0.731 | 0.89 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 1989 | 2019 | ||||||||
|
G protein subunit alpha q | 0.516 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.967 | 0 | 0 | 1989 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.800 | None | 1.000 | 0 | 0 | 1984 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.500 | None | 0.967 | 0 | 0 | 1992 | 2020 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
disease | 0.670 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
melanocyte inducing transcription factor | 0.499 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.974 | 0 | 0 | 2002 | 2020 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1993 | 2018 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.969 | 0 | 0 | 1987 | 2020 | ||||||||
|
p21 (RAC1) activated kinase 1 | 0.494 | 0.808 | 1.3E-03 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2004 | 2017 |